Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11312770 Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Patent 11312770 was granted and assigned to Xencor on April, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Xencor

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113127700

Patent Inventor Names

Umesh Muchhal0

John Desjarlais0

Matthew Bernett0

Michael Hedvat0

Alex Nisthal0

Christine Bonzon0

Gregory Moore0

Date of Patent

April 26, 2022

Patent Application Number

161848950

Date Filed

November 8, 2018

Patent Citations

‌

US Patent 10787518 Bispecific checkpoint inhibitor antibodies

Patent Citations Received

‌

US Patent 11492407 Bispecific checkpoint inhibitor antibodies

Patent Primary Examiner

‌

Nelson B Moseley, II

The present invention is directed to bispecific, heterodimeric checkpoint antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11312770 Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API